Zhengrong Wu

Sir Run Run Shaw Hospital
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.

Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.

Journal: Oncotarget

Published: April 24, 2026

Comparative analysis of minimally invasive approaches for gallbladder and common bile duct stones: combined endoscopic techniques vs. ERCP with laparoscopic cholecystectomy.

Comparative analysis of minimally invasive approaches for gallbladder and common bile duct stones: combined endoscopic techniques vs. ERCP with laparoscopic cholecystectomy.

Journal: Frontiers in surgery

Published: December 11, 2024

Case report: A case study on the treatment using icaritin soft capsules in combination with lenvatinib achieving impressive PR and stage reduction in unresectable locally progressive pancreatic cancer and a literature review.

Case report: A case study on the treatment using icaritin soft capsules in combination with lenvatinib achieving impressive PR and stage reduction in unresectable locally progressive pancreatic cancer and a literature review.

Journal: Frontiers in genetics

Published: February 16, 2023

Analysis of the risk factors for secondary hemorrhage after abdominal surgery.

Analysis of the risk factors for secondary hemorrhage after abdominal surgery.

Journal: Frontiers in surgery

Published: November 06, 2022

Silencing Of hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation Of microRNA-214-3p/EZH2 Axis.

Silencing Of hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation Of microRNA-214-3p/EZH2 Axis.

Journal: Cancer management and research

Published: July 10, 2019

IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer.

IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer.

Journal: BMC cancer

Published: February 28, 2019

Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma.

Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma.

Journal: Journal of Cancer

Published: November 03, 2018

The distinct role of CD73 in the progression of pancreatic cancer.

The distinct role of CD73 in the progression of pancreatic cancer.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: October 06, 2018

Expression of DEK in pancreatic cancer and its correlation with clinicopathological features and prognosis.

Expression of DEK in pancreatic cancer and its correlation with clinicopathological features and prognosis.

Journal: Journal of Cancer

Published: May 22, 2018

A novel scoring system to analyze combined effect of lifestyle factors on pancreatic cancer risk: a retrospective case-control study.

A novel scoring system to analyze combined effect of lifestyle factors on pancreatic cancer risk: a retrospective case-control study.

Journal: Scientific reports

Published: May 10, 2017

Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma.

Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma.

Journal: Cancer biomarkers : section A of Disease markers

Published: November 05, 2016

Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p.

Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p.

Journal: Oncotarget

Published: April 05, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026